International guidelines suggested that overweight and underweight are risk factors for frailty. However, body composition, which directly affects body weight, was not mentioned as a risk factor. We aimed to investigate whether the body composition, including muscle, fat, bone, and body water, is a risk factor for frailty. MEDLINE, Cumulative Index to Nursing and Allied Health Literature, and Scopus were searched up to June 03, 2022. We included cohort studies or observational studies using a cross-sectional design that reported an association between body composition and frailty. Two reviewers assessed the quality of the included cohort studies. Furthermore, we examined whether body composition as a risk factor for frailty varies depending on the participant's place of residence. Of the 3871 retrieved studies, 77 were ultimately included, 7 of which were cohort studies. The risk-of-bias evaluation in each cohort study showed that all studies had at least one concern. Low lean mass, waist circumference-defined abdominal obesity, and bone mineral density were significantly associated with frailty in the cohort studies. The results of bone mineral density were conflicted in the cross-sectional studies. Considering the participants' place of residence, a significant association between lower-extremity muscle mass and frailty was demonstrated, particularly among Asian residents. Low lean mass and abdominal obesity were likely risk factors for frailty. These results could be useful for developing frailty prevention strategies and could have a positive impact on individual health management. Further, future studies are needed because body composition affecting frailty may differ by race.
{"title":"A systematic review of the relationship between body composition including muscle, fat, bone, and body water and frailty in Asian residents.","authors":"Kazuaki Hamada, Tsubasa Mitsutake, Tomonari Hori, Yoshitaka Iwamoto, Naoki Deguchi, Takeshi Imura, Ryo Tanaka","doi":"10.18999/nagjms.87.1.1","DOIUrl":"10.18999/nagjms.87.1.1","url":null,"abstract":"<p><p>International guidelines suggested that overweight and underweight are risk factors for frailty. However, body composition, which directly affects body weight, was not mentioned as a risk factor. We aimed to investigate whether the body composition, including muscle, fat, bone, and body water, is a risk factor for frailty. MEDLINE, Cumulative Index to Nursing and Allied Health Literature, and Scopus were searched up to June 03, 2022. We included cohort studies or observational studies using a cross-sectional design that reported an association between body composition and frailty. Two reviewers assessed the quality of the included cohort studies. Furthermore, we examined whether body composition as a risk factor for frailty varies depending on the participant's place of residence. Of the 3871 retrieved studies, 77 were ultimately included, 7 of which were cohort studies. The risk-of-bias evaluation in each cohort study showed that all studies had at least one concern. Low lean mass, waist circumference-defined abdominal obesity, and bone mineral density were significantly associated with frailty in the cohort studies. The results of bone mineral density were conflicted in the cross-sectional studies. Considering the participants' place of residence, a significant association between lower-extremity muscle mass and frailty was demonstrated, particularly among Asian residents. Low lean mass and abdominal obesity were likely risk factors for frailty. These results could be useful for developing frailty prevention strategies and could have a positive impact on individual health management. Further, future studies are needed because body composition affecting frailty may differ by race.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"1-21"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143994258","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Heparinized saline is used to prevent catheter obstruction; however, it is associated with concerns regarding the incidence of heparin-induced thrombocytopenia and the accuracy of the blood test results. This study compared the impact of saline with and without heparin on central venous catheter occlusion rates in post-surgical intensive care unit patients using a prospective, double-blinded, randomized, controlled design. Patients aged 20-90 years planned to experience central venous catheter insertion and postoperative intensive care unit admission were enrolled and were randomly assigned to either the heparin group (administered normal saline with heparin) or the control group (administered normal saline alone), based on a 1:1 ratio. Nurses blinded to patient allocation performed the occlusion assessment (every 24 h). The Kaplan-Meier curve was used to assess the time to occlusion or removal of each catheter. Central venous catheter insertion results of 136 patients showed no significant variation in occlusion rates between the heparin and control groups within the first 3 days. There was no significant difference between normal saline with and without heparin in preventing central venous occlusion in the intensive care unit up to 3 days post-surgery. The results of this study suggest that it is not necessary to use normal saline with heparin in the management of central venous catheter occlusion, at least when moving from the operating room to the intensive care unit.
{"title":"Prevention of central venous catheter occlusion by saline with or without heparin in intensive care unit after surgical intervention: a double-blind, randomized trial.","authors":"Masayuki Nakamoto, Takahiro Tamura, Eri Kobayashi, Mariko Kawaguchi, Yuri Matsuoka, Akiko Fujii, Masahiko Ando, Yoko Kubo, Takahiro Imaizumi, Yasuhiro Miyagawa, Takayuki Inagaki, Shogo Suzuki, Kimitoshi Nishiwaki","doi":"10.18999/nagjms.87.1.51","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.51","url":null,"abstract":"<p><p>Heparinized saline is used to prevent catheter obstruction; however, it is associated with concerns regarding the incidence of heparin-induced thrombocytopenia and the accuracy of the blood test results. This study compared the impact of saline with and without heparin on central venous catheter occlusion rates in post-surgical intensive care unit patients using a prospective, double-blinded, randomized, controlled design. Patients aged 20-90 years planned to experience central venous catheter insertion and postoperative intensive care unit admission were enrolled and were randomly assigned to either the heparin group (administered normal saline with heparin) or the control group (administered normal saline alone), based on a 1:1 ratio. Nurses blinded to patient allocation performed the occlusion assessment (every 24 h). The Kaplan-Meier curve was used to assess the time to occlusion or removal of each catheter. Central venous catheter insertion results of 136 patients showed no significant variation in occlusion rates between the heparin and control groups within the first 3 days. There was no significant difference between normal saline with and without heparin in preventing central venous occlusion in the intensive care unit up to 3 days post-surgery. The results of this study suggest that it is not necessary to use normal saline with heparin in the management of central venous catheter occlusion, at least when moving from the operating room to the intensive care unit.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"51-59"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004003/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143991886","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Chronic obstructive pulmonary disease is one of the leading causes of death worldwide and in Japan. This study aimed to detect the location and area of spatial clusters with high chronic obstructive pulmonary disease mortality rates in Japan during 2017-2021. Age-standardized numbers of expected chronic obstructive pulmonary disease deaths by sex and municipality were estimated from publicly available data from 1,895 municipalities in Japan. We performed flexible spatial scan statistics to detect the clusters with significantly high risk of chronic obstructive pulmonary disease death using the expected and observed cumulative mortality. During 2017-2021, the cumulative expected number of chronic obstructive pulmonary disease deaths was 87,450 (72,551 males and 14,899 females). There were 23 significant spatial clusters for males and 14 for females. The 23 clusters were scattered in 251 municipalities of 27 prefectures for males, while the 14 clusters for females were localized in 105 municipalities of 12 prefectures. The primary cluster for both sexes was detected in the Osaka Prefecture (males: log-likelihood ratio [LLR] = 188.23, relative risk [RR] = 1.46, p = 0.001; females: LLR = 106.42, RR = 1.95, p = 0.001). We found 23 significant spatial clusters for males and 14 for females. There were obvious sex differences in the distribution of the clusters. Our findings provide supporting evidence to discuss the prioritized areas in the allocation of health care resources to prevent and control the deaths associated with chronic obstructive pulmonary disease.
慢性阻塞性肺病是全世界和日本的主要死亡原因之一。本研究旨在检测2017-2021年日本慢性阻塞性肺疾病高死亡率空间集群的位置和面积。根据日本1,895个城市的公开数据,按性别和城市分列的慢性阻塞性肺病预期死亡年龄标准化数字进行了估计。我们使用预期和观察到的累积死亡率进行了灵活的空间扫描统计,以检测慢性阻塞性肺疾病死亡风险显著高的群集。2017-2021年期间,慢性阻塞性肺疾病死亡的累积预期人数为87,450人(男性72,551人,女性14,899人)。男性有23个显著空间集群,女性有14个显著空间集群。23个男性集群分布在27个州的251个市,14个女性集群分布在12个州的105个市。在大阪府发现了两性的主要聚集性病例(男性:对数似然比[LLR] = 188.23,相对危险度[RR] = 1.46, p = 0.001;女性:LLR = 106.42, RR = 1.95, p = 0.001)。我们发现男性有23个显著的空间集群,女性有14个显著的空间集群。聚类分布存在明显的性别差异。我们的研究结果为讨论卫生保健资源分配的优先领域提供了支持证据,以预防和控制与慢性阻塞性肺疾病相关的死亡。
{"title":"Spatial clusters with high mortality rates for chronic obstructive pulmonary disease among municipalities in Japan between 2017 and 2021: a flexible spatial scan statistics approach.","authors":"Kakei Iwahara, Mayumi Mizutani, Ritsuko Nishide, Susumu Tanimura","doi":"10.18999/nagjms.87.1.133","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.133","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease is one of the leading causes of death worldwide and in Japan. This study aimed to detect the location and area of spatial clusters with high chronic obstructive pulmonary disease mortality rates in Japan during 2017-2021. Age-standardized numbers of expected chronic obstructive pulmonary disease deaths by sex and municipality were estimated from publicly available data from 1,895 municipalities in Japan. We performed flexible spatial scan statistics to detect the clusters with significantly high risk of chronic obstructive pulmonary disease death using the expected and observed cumulative mortality. During 2017-2021, the cumulative expected number of chronic obstructive pulmonary disease deaths was 87,450 (72,551 males and 14,899 females). There were 23 significant spatial clusters for males and 14 for females. The 23 clusters were scattered in 251 municipalities of 27 prefectures for males, while the 14 clusters for females were localized in 105 municipalities of 12 prefectures. The primary cluster for both sexes was detected in the Osaka Prefecture (males: log-likelihood ratio [LLR] = 188.23, relative risk [RR] = 1.46, <i>p</i> = 0.001; females: LLR = 106.42, RR = 1.95, <i>p</i> = 0.001). We found 23 significant spatial clusters for males and 14 for females. There were obvious sex differences in the distribution of the clusters. Our findings provide supporting evidence to discuss the prioritized areas in the allocation of health care resources to prevent and control the deaths associated with chronic obstructive pulmonary disease.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"133-143"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004005/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144039996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Thi Hong Chuyen Nguyen, Tran Bao Song Nguyen, Thanh Phuc Nguyen, Thi Minh Thi Ha, Nguyen Cuong Pham, Thi Thu Giang Nguyen, Minh Tri Phan, Thanh Huy Le, Thanh Thanh Ha, Tran Thuc Huan Nguyen, Cong Thuan Dang
Gastric cancer is a common malignancy disease with a poor prognosis. Deficient mismatch repair is a prognostic and predictive marker of response to systemic therapies. However, deficient mismatch repair frequency and the relationship between this status and microscopic characteristics are inconsistent across nations. We aimed to determine the rate of deficient mismatch repair and its association with histopathological features in gastric cancer patients. A cross-sectional study was conducted on 226 gastric cancer patients treated at Hue University of Medicine and Pharmacy Hospital and Hue Central Hospital from June 2020 to January 2024. Mismatch repair protein expression was evaluated using immunohistochemical staining, and any absence of mismatch repair proteins was regarded as deficient mismatch repair. The deficient mismatch repair rate was 12.8%. Deficient mismatch repair appeared to be more frequent in the intestinal subtype of Lauren classification odds ratio (OR) = 4.767 (95% confidence interval [CI], 1.086-20.921; p = 0.039), tubular/papillary adenocarcinoma (OR = 5.25; 95% CI, 1.185-23.251; p = 0.029), mucinous adenocarcinoma (OR = 6.19; 95% CI, 1.113-34.445; p = 0.037), and differentiated type (OR = 3.24; 95% CI, 1.324-7.931; p = 0.01). No statistically significant association was detected with histopathological features according to the Tumor Location-Modified Lauren classification and mucinous secreting morphology. Deficient mismatch repair status was unusual in gastric cancer. The degree of cell differentiation and microscopic characteristics based on the World Health Organization and Lauren classification could all impact the predictive power for microsatellite-instable status.
{"title":"Mismatch repair deficiency and its relationship with histopathological features in gastric cancer patients.","authors":"Thi Hong Chuyen Nguyen, Tran Bao Song Nguyen, Thanh Phuc Nguyen, Thi Minh Thi Ha, Nguyen Cuong Pham, Thi Thu Giang Nguyen, Minh Tri Phan, Thanh Huy Le, Thanh Thanh Ha, Tran Thuc Huan Nguyen, Cong Thuan Dang","doi":"10.18999/nagjms.87.1.93","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.93","url":null,"abstract":"<p><p>Gastric cancer is a common malignancy disease with a poor prognosis. Deficient mismatch repair is a prognostic and predictive marker of response to systemic therapies. However, deficient mismatch repair frequency and the relationship between this status and microscopic characteristics are inconsistent across nations. We aimed to determine the rate of deficient mismatch repair and its association with histopathological features in gastric cancer patients. A cross-sectional study was conducted on 226 gastric cancer patients treated at Hue University of Medicine and Pharmacy Hospital and Hue Central Hospital from June 2020 to January 2024. Mismatch repair protein expression was evaluated using immunohistochemical staining, and any absence of mismatch repair proteins was regarded as deficient mismatch repair. The deficient mismatch repair rate was 12.8%. Deficient mismatch repair appeared to be more frequent in the intestinal subtype of Lauren classification odds ratio (OR) = 4.767 (95% confidence interval [CI], 1.086-20.921; p = 0.039), tubular/papillary adenocarcinoma (OR = 5.25; 95% CI, 1.185-23.251; p = 0.029), mucinous adenocarcinoma (OR = 6.19; 95% CI, 1.113-34.445; p = 0.037), and differentiated type (OR = 3.24; 95% CI, 1.324-7.931; p = 0.01). No statistically significant association was detected with histopathological features according to the Tumor Location-Modified Lauren classification and mucinous secreting morphology. Deficient mismatch repair status was unusual in gastric cancer. The degree of cell differentiation and microscopic characteristics based on the World Health Organization and Lauren classification could all impact the predictive power for microsatellite-instable status.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"93-104"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144002701","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Intraoperative magnetic resonance imaging (iMRI) plays a crucial role in improving the precision of brain tumor surgeries. However, the use of iMRI can impose certain limitations on intraoperative head positioning. In regular microscopic surgery, head positioning is of utmost importance because an appropriate surgical field is important for the efficacy and safety of surgery. Therefore, in cases where adequate head positioning is difficult, usually, iMRI will not be utilized. Herein, we report an adult case of cerebellar astrocytoma whose tumor extended to the culmen of the cerebellum. Upon surgery via the suboccipital approach, the positional limitations imposed by iMRI led to an insufficient vertex-down position and limited surgical field, which hampered the removal of the upper portion of the tumor. However, this concern could be overcome when used in combination with an endoscope. The potential of iMRI applications is anticipated to be enhanced by overcoming positional limitations through combined endoscopic surgery. The use of multimodality in surgery is an optimal example of how surgical support equipment can also improve surgical outcomes. Here, we report on the new possibilities offered by multimodality.
{"title":"Endoscope-assisted brain tumor removal overcomes the restriction of using intraoperative open magnetic resonance imaging in the suboccipital approach.","authors":"Kei Sasaki, Fumiharu Ohka, Kazuya Motomura, Yuichi Nagata, Kazuhito Takeuchi, Ryuta Saito","doi":"10.18999/nagjms.87.1.168","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.168","url":null,"abstract":"<p><p>Intraoperative magnetic resonance imaging (iMRI) plays a crucial role in improving the precision of brain tumor surgeries. However, the use of iMRI can impose certain limitations on intraoperative head positioning. In regular microscopic surgery, head positioning is of utmost importance because an appropriate surgical field is important for the efficacy and safety of surgery. Therefore, in cases where adequate head positioning is difficult, usually, iMRI will not be utilized. Herein, we report an adult case of cerebellar astrocytoma whose tumor extended to the culmen of the cerebellum. Upon surgery via the suboccipital approach, the positional limitations imposed by iMRI led to an insufficient vertex-down position and limited surgical field, which hampered the removal of the upper portion of the tumor. However, this concern could be overcome when used in combination with an endoscope. The potential of iMRI applications is anticipated to be enhanced by overcoming positional limitations through combined endoscopic surgery. The use of multimodality in surgery is an optimal example of how surgical support equipment can also improve surgical outcomes. Here, we report on the new possibilities offered by multimodality.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"168-172"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143991603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The number of individuals with age-related mild cognitive impairment and subsequent dementia has inevitably increased with the rise in population aging. It is important to maintain cognitive function or decelerate declines in cognitive function. However, the evidence on lifestyle-based factors associated with this decline is lacking. Here, we investigated modifiable lifestyle-based factors associated with chronological cognitive decline in cognitively healthy adults aged ≥60 years (Mini-Mental State Examination [MMSE] score ≥27). This case-control study enrolled 363 participants who were divided into two groups based on annual declines in MMSE score: 40 cases with an MMSE score decline of ≥0.5 points/year and 323 controls with maintained MMSE scores. Smoking, lower social functioning scores on the 36-Item Short Form Health Survey version 2, higher Pittsburgh Sleep Quality Index (PSQI) global scores, and sleep disorders were significantly associated with a decline in MMSE scores. Multivariate logistic regression analysis revealed higher age, current smoking status, and either higher PSQI global scores or sleep disorders to be independently associated with MMSE score decline. In conclusion, the present study identified aging, smoking, and sleep quality as factors associated with a greater decline in MMSE scores in cognitively healthy individuals. Our findings highlight the potential importance of lifestyle factors in preventing cognitive decline.
随着人口老龄化的加剧,与年龄相关的轻度认知障碍和随后的痴呆的个体数量不可避免地增加。重要的是维持认知功能或减缓认知功能的下降。然而,与这种下降有关的生活方式因素的证据是缺乏的。在这里,我们调查了与年龄≥60岁的认知健康成人(迷你精神状态检查[MMSE]评分≥27)的时间顺序认知衰退相关的可改变的生活方式因素。这项病例对照研究招募了363名参与者,根据MMSE评分的年下降率分为两组:40例MMSE评分下降≥0.5分/年,323例对照组MMSE评分维持不变。吸烟、较低的社会功能得分(36-Item Short Form Health Survey version 2)、较高的匹兹堡睡眠质量指数(PSQI)整体得分和睡眠障碍与MMSE得分的下降显著相关。多因素logistic回归分析显示,较高的年龄、当前吸烟状况、较高的PSQI总体评分或睡眠障碍与MMSE评分下降独立相关。总之,本研究确定衰老、吸烟和睡眠质量是认知健康个体MMSE得分下降幅度较大的相关因素。我们的发现强调了生活方式因素在预防认知能力下降方面的潜在重要性。
{"title":"Associations among smoking, sleep quality, and decline in Mini-Mental State Examination scores based on health check-up data in Japan: a case-control study.","authors":"Masahiro Nakatochi, Kei Yoshida, Masaya Fujitani, Yuki Ohashi, Fumie Kinoshita, Yumiko Kobayashi, Hiroyuki Sato, Yoshiko Takahashi, Koichi Murashita, Akihiro Hirakawa","doi":"10.18999/nagjms.87.1.105","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.105","url":null,"abstract":"<p><p>The number of individuals with age-related mild cognitive impairment and subsequent dementia has inevitably increased with the rise in population aging. It is important to maintain cognitive function or decelerate declines in cognitive function. However, the evidence on lifestyle-based factors associated with this decline is lacking. Here, we investigated modifiable lifestyle-based factors associated with chronological cognitive decline in cognitively healthy adults aged ≥60 years (Mini-Mental State Examination [MMSE] score ≥27). This case-control study enrolled 363 participants who were divided into two groups based on annual declines in MMSE score: 40 cases with an MMSE score decline of ≥0.5 points/year and 323 controls with maintained MMSE scores. Smoking, lower social functioning scores on the 36-Item Short Form Health Survey version 2, higher Pittsburgh Sleep Quality Index (PSQI) global scores, and sleep disorders were significantly associated with a decline in MMSE scores. Multivariate logistic regression analysis revealed higher age, current smoking status, and either higher PSQI global scores or sleep disorders to be independently associated with MMSE score decline. In conclusion, the present study identified aging, smoking, and sleep quality as factors associated with a greater decline in MMSE scores in cognitively healthy individuals. Our findings highlight the potential importance of lifestyle factors in preventing cognitive decline.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"105-121"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144022434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Catheter ablation is the first-line treatment for atrial fibrillation. Although the efficacy and safety of this procedure have been reported in older patients, they might diminish with age. Therefore, this study aimed to determine the safety and effectiveness of atrial fibrillation ablation in patients aged ≥80 years. We retrospectively analyzed the features of the catheter ablation and the subsequent clinical course and outcomes of 100 patients with atrial fibrillation aged ≥80 years who underwent ablation between July 2019 and December 2021 at Tosei General Hospital, Seto, Aichi, Japan. The average duration of atrial fibrillation was 6.0 ± 9.5 months, and 83% of the patients were symptomatic. Approximately 30% of patients developed heart failure, with 15% requiring hospitalization within one year before ablation. After ablation, 93% of patients were atrial fibrillation-free, and none required postoperative hospitalization due to heart failure. However, several complications have been observed, including cardiac tamponade, hematoma at the access site, and postoperative bradycardia. Notably, an enlarged left atrial diameter before ablation is a predictor of complications. In patients aged ≥80 years, atrial fibrillation ablation therapy demonstrated a high non-recurrence rate and may alter the progression of heart failure. Although the incidence of complications was relatively low, caution should be exercised when older patients with enlarged left atrial diameters undergo atrial fibrillation ablation.
{"title":"Efficacy and safety of atrial fibrillation ablation in patients aged ≥80 years: a retrospective study.","authors":"Yusuke Sakamoto, Hiroyuki Osanai, Yuki Tanaka","doi":"10.18999/nagjms.87.1.37","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.37","url":null,"abstract":"<p><p>Catheter ablation is the first-line treatment for atrial fibrillation. Although the efficacy and safety of this procedure have been reported in older patients, they might diminish with age. Therefore, this study aimed to determine the safety and effectiveness of atrial fibrillation ablation in patients aged ≥80 years. We retrospectively analyzed the features of the catheter ablation and the subsequent clinical course and outcomes of 100 patients with atrial fibrillation aged ≥80 years who underwent ablation between July 2019 and December 2021 at Tosei General Hospital, Seto, Aichi, Japan. The average duration of atrial fibrillation was 6.0 ± 9.5 months, and 83% of the patients were symptomatic. Approximately 30% of patients developed heart failure, with 15% requiring hospitalization within one year before ablation. After ablation, 93% of patients were atrial fibrillation-free, and none required postoperative hospitalization due to heart failure. However, several complications have been observed, including cardiac tamponade, hematoma at the access site, and postoperative bradycardia. Notably, an enlarged left atrial diameter before ablation is a predictor of complications. In patients aged ≥80 years, atrial fibrillation ablation therapy demonstrated a high non-recurrence rate and may alter the progression of heart failure. Although the incidence of complications was relatively low, caution should be exercised when older patients with enlarged left atrial diameters undergo atrial fibrillation ablation.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"37-50"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004001/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144051572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-02-01DOI: 10.18999/nagjms.87.1.163
Sidar Şiyar Aydın, Onur Furkan Akgün, Taha Karabacak, Ali Bilal Ulaş, Yavuzer Koza
Kounis syndrome (KS) manifests as an acute coronary syndrome triggered by allergy, hypersensitivity, or anaphylaxis. It is believed that mast cells and histamine can potentially induce acute cardiac events by activating various inflammatory pathways. Here, we present a case of KS triggered by rifampicin administered during empyema drainage in a young male patient with no history of coronary artery disease. To the best of our knowledge, our case is the first report of rifampicin-induced KS documented in the literature. The wide range of etiological factors complicates the diagnosis of KS. Healthcare professionals should consider KS as a potential diagnosis in patients experiencing angina or similar pain alongside suspected allergic reactions.
{"title":"Rifampicin-induced type 1 Kounis syndrome: a rare case.","authors":"Sidar Şiyar Aydın, Onur Furkan Akgün, Taha Karabacak, Ali Bilal Ulaş, Yavuzer Koza","doi":"10.18999/nagjms.87.1.163","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.163","url":null,"abstract":"<p><p>Kounis syndrome (KS) manifests as an acute coronary syndrome triggered by allergy, hypersensitivity, or anaphylaxis. It is believed that mast cells and histamine can potentially induce acute cardiac events by activating various inflammatory pathways. Here, we present a case of KS triggered by rifampicin administered during empyema drainage in a young male patient with no history of coronary artery disease. To the best of our knowledge, our case is the first report of rifampicin-induced KS documented in the literature. The wide range of etiological factors complicates the diagnosis of KS. Healthcare professionals should consider KS as a potential diagnosis in patients experiencing angina or similar pain alongside suspected allergic reactions.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"163-167"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144055969","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Since the COVID-19 pandemic, it has been found that SARS-CoV-2 antecedent infection can cause multisystem inflammatory syndrome in children. However, the frequency of SARS-CoV-2 antecedent infection in Kawasaki disease (KD) is unknown. The purpose of this study was to investigate the frequency of SARS-CoV-2 infection that preceded the onset of KD. This study is a multi-center observational study. The subjects were patients who were diagnosed with KD at 4 hospitals from April 1, 2020 to August 31, 2022. Serum SARS-CoV-2 IgM and total antibody including IgG levels were measured by the chemiluminescence immunoassay method before and after treatment for KD. A total of 55 patients participated in the study. The first antibody measurement before the initial treatment was performed on a median of 4th days of illness and the second antibody measurement was performed after the initial treatment on a median of 12th days of illness. No patient had a significant increase in SARS-CoV-2 IgM levels in two measurements. Only one patient (1.8%) had elevated total antibodies including IgG, and the patient had a history of COVID-19 6 months before the onset of KD. SARS-CoV-2 antecedent infection before the onset of KD was not observed in this study, and strong association between development of KD and SARS-CoV-2 infection was not suggested.
{"title":"Frequency of SARS-CoV-2 antecedent infection in patients with Kawasaki disease.","authors":"Kiyotaka Go, Yoshihiko Kawano, Noriko Nagai, Daisuke Omori, Yoshihito Morimoto, Hidenori Yamamoto, Yoshie Fukasawa, Yoshinori Ito, Yoshiyuki Takahashi, Taichi Kato","doi":"10.18999/nagjms.87.1.76","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.76","url":null,"abstract":"<p><p>Since the COVID-19 pandemic, it has been found that SARS-CoV-2 antecedent infection can cause multisystem inflammatory syndrome in children. However, the frequency of SARS-CoV-2 antecedent infection in Kawasaki disease (KD) is unknown. The purpose of this study was to investigate the frequency of SARS-CoV-2 infection that preceded the onset of KD. This study is a multi-center observational study. The subjects were patients who were diagnosed with KD at 4 hospitals from April 1, 2020 to August 31, 2022. Serum SARS-CoV-2 IgM and total antibody including IgG levels were measured by the chemiluminescence immunoassay method before and after treatment for KD. A total of 55 patients participated in the study. The first antibody measurement before the initial treatment was performed on a median of 4th days of illness and the second antibody measurement was performed after the initial treatment on a median of 12th days of illness. No patient had a significant increase in SARS-CoV-2 IgM levels in two measurements. Only one patient (1.8%) had elevated total antibodies including IgG, and the patient had a history of COVID-19 6 months before the onset of KD. SARS-CoV-2 antecedent infection before the onset of KD was not observed in this study, and strong association between development of KD and SARS-CoV-2 infection was not suggested.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"76-83"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12004000/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144004124","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Distinguishing recurrent cholangiocarcinoma lesions from postoperative fibrosis or biliojejunostomy lesions using contrast-enhanced computed tomography (CECT) alone is challenging. This study examined the value of adding diffusion-weighted magnetic resonance imaging (DWI) to CECT for the detection of cholangiocarcinoma recurrence. This single-institution retrospective analysis included 33 patients who underwent cholangiocarcinoma resection between January 2016 and December 2020. Of the patients, 20 were in the recurrence group and 13 were in the non-recurrence group. Two observers independently reviewed the CECT images and subsequently reviewed the combined CECT and DWI images (b-value, 1000 s/mm2), with each image reviewed twice. The diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Kappa statistics were used to evaluate agreement. The diagnostic performance (area under the ROC curve [AUC]) of both observers improved after the addition of DWI; the AUC improved from 0.614 to 0.918 (P = 0.003) in the first session and from 0.820 to 0.928 (P = 0.20) in the second session for Observer A, whereas it improved from 0.566 to 0.858 (P < 0.001) in the first session and from 0.753 to 0.930 (P = 0.02) in the second session for Observer B. The intraobserver and interobserver agreements improved after the addition of DWI; the kappa value improved from 0.586 to 0.656 for Observer A, from 0.371 to 0.838 for Observer B, from 0.308 to 0.766 in the first session, and from 0.464 to 0.620 in the second session. Adding DWI to CECT improves the detection of cholangiocarcinoma recurrence compared to CECT alone.
{"title":"Added value of diffusion-weighted magnetic resonance imaging in the diagnosis of recurrent cholangiocarcinoma.","authors":"Keiichiro Yamada, Yasuo Takehara, Satoko Ishigaki, Hiroshi Ogawa, Ayumi Nishida, Keita Kato, Tomoki Ebata, Takashi Mizuno, Shinji Naganawa","doi":"10.18999/nagjms.87.1.22","DOIUrl":"https://doi.org/10.18999/nagjms.87.1.22","url":null,"abstract":"<p><p>Distinguishing recurrent cholangiocarcinoma lesions from postoperative fibrosis or biliojejunostomy lesions using contrast-enhanced computed tomography (CECT) alone is challenging. This study examined the value of adding diffusion-weighted magnetic resonance imaging (DWI) to CECT for the detection of cholangiocarcinoma recurrence. This single-institution retrospective analysis included 33 patients who underwent cholangiocarcinoma resection between January 2016 and December 2020. Of the patients, 20 were in the recurrence group and 13 were in the non-recurrence group. Two observers independently reviewed the CECT images and subsequently reviewed the combined CECT and DWI images (b-value, 1000 s/mm<sup>2</sup>), with each image reviewed twice. The diagnostic performance was evaluated using receiver operating characteristic (ROC) curve analysis. Kappa statistics were used to evaluate agreement. The diagnostic performance (area under the ROC curve [AUC]) of both observers improved after the addition of DWI; the AUC improved from 0.614 to 0.918 (<i>P</i> = 0.003) in the first session and from 0.820 to 0.928 (<i>P</i> = 0.20) in the second session for Observer A, whereas it improved from 0.566 to 0.858 (<i>P</i> < 0.001) in the first session and from 0.753 to 0.930 (<i>P</i> = 0.02) in the second session for Observer B. The intraobserver and interobserver agreements improved after the addition of DWI; the kappa value improved from 0.586 to 0.656 for Observer A, from 0.371 to 0.838 for Observer B, from 0.308 to 0.766 in the first session, and from 0.464 to 0.620 in the second session. Adding DWI to CECT improves the detection of cholangiocarcinoma recurrence compared to CECT alone.</p>","PeriodicalId":49014,"journal":{"name":"Nagoya Journal of Medical Science","volume":"87 1","pages":"22-36"},"PeriodicalIF":0.9,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12003994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144042534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}